Linda J. Van Eldik is at the forefront of the crusade to help a growing population of older adults age in healthy ways. She helms the University of Kentucky Sanders-Brown Center on Aging (SBCoA), home to the federally-funded UK Alzheimer's Disease Center (ADC).
SBCoA News
Nov 19, 2012 -
"Good enough…isn't," said heroic pilot Captain Chesley "Sully" Sullenberger when speaking at the 2012 University of Kentucky Sanders-Brown Center on Aging Annual Dinner. Sullenberger headlined the fundraiser, which took place Nov. 14 in downtown Lexington.
Oct 12, 2012 -
"The reward I want is a cure for this disease. That is all the incentive I need." — University of Kentucky Sanders-Brown Center on Aging research volunteer. For more than 20 years, volunteers have left a legacy by giving of themselves in the fight against Alzheimer's disease.
Oct 03, 2012 -
Donna Wilcock, assistant professor of physiology and member of the faculty of the University of Kentucky Sanders-Brown Center on Aging, is the recipient of a $1.5 million grant from the National Institutes of Health. The grant will enable Wilcock and her laboratory to study the relationship between cerebrovascular disease and Alzheimer's disease.
Sep 21, 2012 -
To mark World Alzheimer's Day on Sept. 21, the University of Kentucky Sanders-Brown Center on Aging announces that it will hold a two-part symposium on Alzheimer's disease in November.
Sep 21, 2012 -
The University of Kentucky Sanders-Brown Center on Aging will co-host a symposium highlighting the link between Down syndrome and aging. The "Adults with Down Syndrome: Applying Research Findings to Healthy Brain Aging" symposium will be held 8:30 am to 2:30 pm Oct. 20. The event is at Down Syndrome of Louisville, Inc., 5001 South Hurstbourne Parkway, Louisville.
Jul 25, 2012 -
In a study published in the Journal of Neuroscience, a collaborative team of researchers led by Linda J. Van Eldik, director of the University of Kentucky Sanders-Brown Center on Aging, and D. Martin Watterson of the Northwestern University Feinberg School of Medicine, present results showing that a new central nervous system drug compound can reduce Alzheimer’s pathology in a mouse model of the disease.
Jul 18, 2012 -
At the 2012 Alzheimer's Association International Conference in Vancouver, a study by Dr. Gregory Jicha and colleagues shows that medical conditions such as hypothyroidism and vitamin deficiency could be the cause of some mild cognitive impairments and hence reversible. He suggested that primary care physicians test for the conditions in patients who may be showing signs of memory decline. Published by ElsGlobalMedicalNews.